Simran Parmar

Sep 1, 2023 | ecrjournal.com | John Beltrame |Peter Ong |Juan Carlos Kaski |Simran Parmar

Average (ratings) Disclosure:PO is a regional editor and JFB is on the European Cardiology Review editorial board; this did not affect peer review. PO has received funding from Berthold Leibinger Foundation and speaker fees from Abbott Medical, Philipps and Pfizer BMS. FC has received speaker fees from Amgen, Astra Zeneca, Abbott, Menarini, Chiesi and Daiichi Sankyo.